Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC

Abroad (travel likely)Recruiting

Conditions

Ureter Cancer · Renal Pelvic Carcinoma · Advanced Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Departmeng of Urology, Peking University First Hospital, Beijing, China
Contact: Study coordinator (Xuesong Li, M.D.) · pineneedle@sina.com · +86-15801399116
Contact: Study coordinator (Chunru Xu, M.D.) · xcrbdyy@126.com · +86-17812172086
Department of Radiotherapy Oncology, Peking University First Hospital, Beijing, China
Contact: Study coordinator (Xianshu Gao, M.D.) · doctorgaoxs@126.com · +86-13716109164
Contact: Study coordinator (Xiaoying Li, M.D.) · 13716109164@139.com · +86-13716109164

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs

Oligometastatic Disease · Ureter Cancer · Renal Pelvic Carcinoma

Abroad (travel likely)Recruiting

Beijing, China · Beijing, China

Integrated Cancer Repository for Cancer Research

Pancreatic Cancer · Thyroid Cancer · Lung Cancer

Abroad (travel likely)Recruiting

Greenwood Village, United States · Manchester, United States

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Metastatic Bladder Urothelial Carcinoma · Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · Refractory Bladder Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE2

Rochester, United States